GenMark Diagnostics Shares Outstanding 2010-2018 | GNMK

GenMark Diagnostics shares outstanding from 2010 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
GenMark Diagnostics Annual Shares Outstanding
(Millions of Shares)
2017 51
2016 44
2015 42
2014 41
2013 35
2012 26
2011 17
2010 10
2009 5
GenMark Diagnostics Quarterly Shares Outstanding
(Millions of Shares)
Q3 2018 56
Q2 2018 56
Q1 2018 55
Q4 2017 51
Q3 2017 55
Q2 2017 48
Q1 2017 47
Q4 2016 44
Q3 2016 44
Q2 2016 43
Q1 2016 43
Q4 2015 42
Q3 2015 42
Q2 2015 42
Q1 2015 42
Q4 2014 41
Q3 2014 41
Q2 2014 41
Q1 2014 41
Q4 2013 35
Q3 2013 36
Q2 2013 32
Q1 2013 32
Q4 2012 26
Q3 2012 32
Q2 2012 21
Q1 2012 20
Q4 2011 20
Q3 2011 20
Q2 2011 14
Q1 2011 12
Q4 2010 12
Q3 2010 12
Q2 2010 9
Q1 2010 7
Q4 2009 5
Q3 2009 5
Q2 2009 4
Q1 2009 4
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.335B $0.053B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $94.457B 22.01
Intuitive Surgical (ISRG) United States $58.919B 57.97
Edwards Lifesciences (EW) United States $32.745B 35.04
Fresenius Medical Care AG KGaA (FMS) Germany $21.185B 14.32
IDEXX Laboratories (IDXX) United States $17.009B 48.58
ABIOMED (ABMD) United States $14.599B 104.90
DexCom (DXCM) United States $13.065B 0.00
Hologic (HOLX) United States $12.427B 19.18
Teleflex (TFX) United States $11.433B 25.95
Varian Medical Systems (VAR) United States $11.421B 28.42
STERIS (STE) United Kingdom $9.401B 24.94
Masimo (MASI) United States $6.157B 39.92
Penumbra (PEN) United States $4.736B 285.98
LivaNova (LIVN) United Kingdom $4.387B 28.16
Globus Medical (GMED) United States $4.190B 26.26
Integra LifeSciences Holdings (IART) United States $3.928B 19.13
Wright Medical Group (WMGI) Netherlands $3.581B 0.00
Cantel Medical (CMD) United States $3.276B 32.31
Inogen (INGN) United States $3.121B 67.36
Integer Holdings (ITGR) United States $2.609B 21.83
Tandem Diabetes Care (TNDM) United States $2.522B 0.00
Glaukos (GKOS) United States $2.123B 0.00
Halyard Health (AVNS) United States $2.108B 18.99
OPKO Health (OPK) United States $2.088B 0.00
Nevro (NVRO) United States $1.261B 0.00
Tactile Systems Technology (TCMD) United States $1.134B 180.50
Luminex (LMNX) United States $1.133B 41.00
Natus Medical (BABY) United States $1.121B 23.56
Pacific Biosciences Of California (PACB) United States $1.083B 0.00
CryoLife (CRY) United States $1.054B 91.93
Orthofix (OFIX) United States $0.964B 27.83
Intersect ENT (XENT) United States $0.873B 0.00
Accelerate Diagnostics (AXDX) United States $0.867B 0.00
Mesa Laboratories (MLAB) United States $0.832B 49.20
AngioDynamics (ANGO) United States $0.772B 25.05
ViewRay (VRAY) United States $0.716B 0.00
Veracyte (VCYT) United States $0.646B 0.00
TransEnterix (TRXC) United States $0.590B 0.00
AxoGen (AXGN) United States $0.560B 0.00
Si-Bone (SIBN) United States $0.538B 0.00
OrthoPediatrics (KIDS) United States $0.411B 0.00
Quotient (QTNT) Switzerland $0.409B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.396B 0.00
Sientra (SIEN) United States $0.381B 0.00
Fluidigm (FLDM) United States $0.340B 0.00
Accuray (ARAY) United States $0.336B 0.00
IRadimed (IRMD) United States $0.287B 74.97
SeaSpine Holdings (SPNE) United States $0.278B 0.00
Neuronetics (STIM) United States $0.263B 0.00
RTI Surgical (RTIX) United States $0.261B 41.20
Nuvectra (NVTR) United States $0.260B 0.00
Pulse Biosciences (PLSE) United States $0.248B 0.00
Corindus Vascular Robotics (CVRS) United States $0.228B 0.00
CRH Medical (CRHM) Canada $0.227B 39.13
Helius Medical Technologies (HSDT) United States $0.217B 0.00
T2 Biosystems (TTOO) United States $0.164B 0.00
Sensus Healthcare (SRTS) United States $0.132B 0.00
Ra Medical Systems (RMED) United States $0.120B 0.00
Ekso Bionics Holdings (EKSO) United States $0.106B 0.00
Alphatec Holdings (ATEC) United States $0.079B 0.00
Biosig Technologies (BSGM) United States $0.073B 0.00
EDAP TMS (EDAP) France $0.072B 0.00
Apollo Endosurgery (APEN) United States $0.071B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.064B 0.00
Second Sight Medical Products (EYES) United States $0.063B 0.00
Vermillion (VRML) United States $0.054B 0.00
Electromed (ELMD) United States $0.042B 20.00
OBALON THERPTCS (OBLN) United States $0.040B 0.00
Titan Medical (TMDI) Canada $0.039B 0.00
Viveve Medical (VIVE) United States $0.037B 0.00
Restoration Robotics (HAIR) United States $0.036B 0.00
ConforMIS (CFMS) United States $0.034B 0.00
Microbot Medical (MBOT) United States $0.030B 0.00
Xtant Medical Holdings (XTNT) United States $0.030B 0.00
PAVmed (PAVM) United States $0.026B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.024B 0.00
Dynatronics (DYNT) United States $0.023B 0.00
DarioHealth (DRIO) Israel $0.020B 0.00
Lianluo Smart (LLIT) China $0.020B 0.00
Neovasc (NVCN) Canada $0.018B 0.00
Bioanalytical Systems (BASI) United States $0.015B 72.00
American Shared Hospital Services (AMS) United States $0.014B 10.96
Nanovibronix (NAOV) United States $0.013B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Presbia (LENS) Ireland $0.009B 0.00
Allied Healthcare Products (AHPI) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.008B 0.00
ReWalk Robotics (RWLK) Israel $0.008B 0.00
Atossa Genetics (ATOS) United States $0.007B 0.00
Cesca Therapeutics (KOOL) United States $0.007B 0.00
Avinger (AVGR) United States $0.007B 0.00
InspireMD (NSPR) Israel $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Amedica (SINT) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.000B 0.00